Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 60 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CPP Clear all

Conditions: Puberty, Precocious
Interventions: Lupron (leuprolide acetate); Drug
Lead sponsor: Abbott; Industry
Eligibility: Up to 10 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2009
U.S. locations: 9
States / cities: Phoenix, Arizona • San Francisco, California • Stanford, California + 6 more

Conditions: Genetic Disorder, Infertility, Hypogonadism, Amenorrhea
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 6 Weeks to 120 Years
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 2
States / cities: Bethesda, Maryland • Research Triangle Park, North Carolina

Conditions: Behavior Problem
Interventions: Chicago Parent Program for Foster Care; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Tooth Demineralization
Interventions: MI Paste Plus, PreviDent Fluoride Varnish, Normal Home Care; Procedure
Lead sponsor: University of Washington; Other
Eligibility: 12 Years to 20 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Parenting, Problem Behavior, Premature Birth, Parenting Intervention
Interventions: ezParent, Coaching calls, Active Control; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 20 Months and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: Chicago, Illinois • Columbus, Ohio

Conditions: Traumatic Brain Injury
Interventions: Full-band Electrocorticography, Treatment Algorithm; Diagnostic Test · Combination Product
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Chronic Pelvic Pain Syndrome
Interventions: Sacral neuromodulation; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 22 Years to 70 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Hypertension
Interventions: Technology-enabled Team Care, Enhanced Usual Care; Other
Lead sponsor: East Carolina University; Other
Eligibility: 19 Years and older
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Greenville, North Carolina • Wilmington, North Carolina

Conditions: Triple Negative Breast Cancer (TNBC), Elevated Tumor-Infiltrating Lymphocytes
Interventions: Carboplatin, Paclitaxcel, Pembrolizumab; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2034
U.S. locations: 2
States / cities: Syracuse, New York • Charleston, South Carolina

Conditions: Interstitial Cystitis, Chronic Pain, Pelvic Floor; Relaxation, Pelvic Floor Disorders
Interventions: High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device, Botulinum Neurotoxin; Device · Drug
Lead sponsor: HillMed Inc.; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Plaque Psoriasis
Interventions: apremilast; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Teeth Sensitivity, Tooth Discoloration
Interventions: CPP-ACP; Drug
Lead sponsor: University of New England; Other
Eligibility: 18 Years to 50 Years
Enrollment: 40 participants
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Demineralization
Interventions: CPP-ACP-NaF varnish; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Pelvic Pain
Interventions: My Pelvic Plan, Bend; Device · Behavioral
Lead sponsor: Sara Till, MD, MPH; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Disruptive Behavior Disorder, Childhood Onset, Disruptive Behavior, Executive Function
Interventions: Chicago Parent Program; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 4 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Pelvic Pain
Interventions: Active tDCS with guided imagery; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 64 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Royal Oak, Michigan

Conditions: Pelvic Pain, Distress, Emotional
Interventions: Brief ACT with CPP Education Treatment; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Cerebral Vasospasm, Autonomic Nervous System Diseases
Interventions: Right-Sided Cervical Sympathetic Block at C6, Transcutaneous Auricular Vagal Nerve Stimulation (taVNS); Procedure · Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Puberty, Precocious
Interventions: Leuprolide acetate 11.25 mg, Leuprolide acetate 30 mg; Drug
Lead sponsor: Abbott; Industry
Eligibility: 2 Years to 11 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 21
States / cities: Birmingham, Alabama • Long Beach, California • Los Angeles, California + 16 more

Conditions: Parenting, Parenting Intervention
Interventions: Chicago Parent Program (CPP); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 840 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Teratoid Tumor, Atypical, Choroid Plexus Neoplasms, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Brainstem Tumors, Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma, Medulloblastoma, Neuroectodermal Tumor, Primitive
Interventions: azurin-derived cell-penetrating peptide p28; Drug
Lead sponsor: Pediatric Brain Tumor Consortium; Network
Eligibility: 3 Years to 21 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 11
States / cities: Los Angeles, California • Palo Alto, California • Washington D.C., District of Columbia + 8 more

Conditions: Behavior Disorders
Interventions: Coping Power Program (CPP), Cognitive behavioral therapy (CBT) for Anxiety Treatment in Schools (CATS), Check-in/Check-out (CI/CO); Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 18 Years to 99 Years
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Pelvic Pain
Interventions: Psilocybin (Usona Institute); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Behavior Disorders
Interventions: Coping Power Program (CPP), CBT for Anxiety Treatment in Schools (CATS), Check-in/Check-out (CI/CO), Initial Training (CC), Initial Training plus Video (RV), Initial Training plus Video plus Coaching (RV+); Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 8 Years to 99 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Study of Lupron Depot In The Treatment of Central Precocious Puberty

Inherited Reproductive Disorders

Tailoring CPP for the Foster Care Setting

Study of Treatments Used for White Spot Lesions After Orthodontic Treatment.

Parent Training for Parents of Toddlers Born Very Premature:

Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)

Sacral Neuromodulation for Chronic Pelvic Pain

Heart to Heart: BP Control Partners

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy

Efficacy of CPP-ACP on Bleaching Related Sensitivity

Prevention of Enamel Demineralization Using CPP-ACP-NaF Varnish

Comparing Integrative Interventions for Chronic Pelvic Pain

Executive Function and Parenting in Childhood

Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP)

Pelvic Pain Education and Skills Training for Women Veterans

Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Resilient, Engaged, and Connected Study

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Remote Training in Rural Schools

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study

Evaluation of a Remote Training Strategy